PARP1 and cancer: As PARP-1 protein contains a DNA-binding domain, which can bind to DNA strand breaks and repair the damaged DNA over a low basal level, the inhibitors of poly(ADR-ribose) polymerase 1 (PARP-1) have been indicated as the agents treated for cancer [14–17].